PH-operated hybrid silica nanoparticles with multiple H-bond stoppers for colon cancer therapy1. Issue 80 (2nd September 2015) - Théron, C.
Abstract Controlled delivery of a chemotherapeutic drug from pH-sensitive hybrid silica nanocarriers efficiently targets colon carcinoma cells. The drug, blocked by cyanuric acid as stopper, is autonomously released inside the cancer cells.